Title: Effects of Telmisartan, Ramipril, and Their Combination on Left Ventricular Hypertrophy in Individuals at High Vascular Risk in the Ongoing Telmisartan Alone and in Combination With Ramipril Global End Point Trial and the Telmisartan Randomized Assessment Study in ACE Intolerant Subjects With Cardiovascular Disease
Authors: Verdecchia, Paolo ×
Sleight, Peter
Mancia, Giuseppe
Fagard, Robert
Trimarco, Bruno
Schmieder, Roland E
Kim, Jae-Hyung
Jennings, Garry
Jansky, Petr
Chen, Jyh-Hong
Liu, Lisheng
Gao, Peggy
Probstfield, Jeffrey
Teo, Koon
Yusuf, Salim #
Issue Date: Oct-2009
Publisher: Lippincott williams & wilkins
Series Title: Circulation vol:120 issue:14 pages:1380-1389
Abstract: Background-Angiotensin-converting enzyme (ACE) inhibitors and angiotensin receptor blockers reduce left ventricular hypertrophy (LVH). The effect of these drugs on LVH in high-risk patients without heart failure is unknown.
ISSN: 0009-7322
Publication status: published
KU Leuven publication type: IT
Appears in Collections:Hypertension and Cardiovascular Epidemiology
× corresponding author
# (joint) last author

Files in This Item:

There are no files associated with this item.

Request a copy


All items in Lirias are protected by copyright, with all rights reserved.

© Web of science